Search results
Results from the WOW.Com Content Network
Abbreviation Meaning pĚ„: after (from Latin post) [1] [letter p with a bar over it] pH Potential of Hydrogen - Acidity of a fluid P: parturition (total number of live births) phosphorus pulse [1] post P OSM: plasma osmolality PA: posterior–anterior, posteroanterior pulmonary artery [[physician assistant or associate [2]]] psoriatic arthritis ...
The prognosis depends on the type of cells affected, the number of blasts in the bone marrow or blood, and the changes present in the chromosomes of the affected cells. [3] The average survival time following diagnosis is 2.5 years. [4] MDS was first recognized in the early 1900s; [5] it came to be called myelodysplastic syndrome in 1976. [5]
Cancer: CACH Childhood ataxia with central nervous system hypomyelination (see vanishing white matter disease) CAD Coronary artery disease: CADASIL: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy CAP Community acquired pneumonia: CAPA COVID-19–associated pulmonary aspergillosis CAPD
In oncology, polycythemia vera (PV) is an uncommon myeloproliferative neoplasm in which the bone marrow makes too many red blood cells. [1] The majority of cases [2] are caused by mutations in the JAK2 gene, most commonly resulting in a single amino acid change in its protein product from valine to phenylalanine at position 617.
Pronunciation follows convention outside the medical field, in which acronyms are generally pronounced as if they were a word (JAMA, SIDS), initialisms are generally pronounced as individual letters (DNA, SSRI), and abbreviations generally use the expansion (soln. = "solution", sup. = "superior").
Cancer staging can be divided into a clinical stage and a pathologic stage. In the TNM (Tumor, Node, Metastasis) system, clinical stage and pathologic stage are denoted by a small "c" or "p" before the stage (e.g., cT3N1M0 or pT2N0). This staging system is used for most forms of cancer, except brain tumors and hematological malignancies.
According to the American Cancer Society, they estimate that there will about 23,690 new cases of CLL with about 4,460 deaths from CLL in the United States throughout 2025. [19] Five-year survival following diagnosis is approximately 83% in the United States. [3] It represents less than 1% of deaths from cancer. [7]
Acute promyelocytic leukemia is characterized by a chromosomal translocation involving the retinoic acid receptor alpha (RARA) gene on chromosome 17. [3] In 95% of cases of APL, the RARA gene on chromosome 17 is involved in a reciprocal translocation with the promyelocytic leukemia gene (PML) on chromosome 15, a translocation denoted as t(15;17)(q22;q21). [3]